Johnson & Johnson (JNJ) receives European Commission's (EC) approval for the label expansion of Stelara for the treatment of adults with moderately-to-severely active ulcerative colitis (UC).
source https://finance.yahoo.com/news/j-js-stelara-gets-approval-141802625.html?.tsrc=rss
blaineonline.finance.blog 